# Antiepileptic Drug Interactions

> Antiepileptic interactions for FMGE Pharmacology: enzyme inducers, OCP failure, valproate-lamotrigine, phenytoin-INH toxicity and meropenem-valproate.

- Canonical URL: https://prepelephant.com/topics/fmge/pharmacology/antiepileptic-drug-interactions-fmge
- Exam / course: FMGE · Subject: Pharmacology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-02
- Last updated: 2026-10-02
- How to cite: "Antiepileptic Drug Interactions", PrepElephant, https://prepelephant.com/topics/fmge/pharmacology/antiepileptic-drug-interactions-fmge

## Direct answer

Enzyme induction is the organising principle of antiepileptic interactions: carbamazepine, phenytoin, phenobarbitone and primidone powerfully induce CYP3A4 and 2C9, accelerating the metabolism of oral contraceptive steroids, warfarin, glucocorticoids, tacrolimus, voriconazole and many antiretrovirals — which is why a woman on phenytoin is counseled that a combined oral contraceptive pill may fail and needs additional protection. Valproate sits at the opposite pole as a broad inhibitor, roughly doubling lamotrigine levels, so lamotrigine titration must be halved and the rash risk respected. Phenytoin saturates metabolism at therapeutic doses, so inhibitors such as isoniazid or fluconazole push it into toxicity with nystagmus and ataxia after small dose changes. The low-interaction modern agents — levetiracetam, gabapentin, pregabalin — avoid this maze altogether, and one bizarre but exam-favoured pair deserves memory: meropenem can collapse serum valproate to subtherapeutic within days.

## What you must remember

- **Strong inducers:** carbamazepine, phenytoin, phenobarbitone, primidone — lower OCP, warfarin, steroid, tacrolimus, quetiapine and voriconazole levels; carbamazepine also autoinduces its own metabolism over the first 3-4 weeks.
- **Contraception counselling:** women on enzyme-inducing antieepileptics need a higher-dose or alternative method — progestogen injection, intrauterine device or barrier add-on; a standard combined pill is unreliable.
- **Valproate the inhibitor:** doubles lamotrigine (halve the dose and titrate slower — Stevens-Johnson risk), raises phenobarbitone and carbamazepine-10,11-epoxide; conversely inducers lower valproate.
- **Lamotrigine is glucuronidated:** oestrogen-containing contraceptives halve its levels, and stopping the pill after years double them — toxicity can appear the month the pill stops.
- **Phenytoin zero-order kinetics:** isoniazid, fluconazole, cimetidine, trimethoprim-sulfamethoxazole and amiodarone inhibit its metabolism; toxicity presents with nystagmus, ataxia and diplopia long before seizures return.
- **NTEP crossover:** daily anti-tubercular therapy containing isoniazid inhibits phenytoin metabolism — a patient on both needs phenytoin level monitoring and often dose reduction; rifampicin does the reverse, inducing phenytoin and lowering valproate.
- **Meropenem-valproate:** carbapenems dramatically reduce valproate levels; breakthrough seizures follow — an interaction now flagged in Indian pharmacovigilance alerts.

## A case that pulls the threads together

A 26-year-old woman on phenytoin 300 mg daily for two years, well controlled, is diagnosed with sputum-positive pulmonary tuberculosis and started on daily antitubercular therapy under the National TB Elimination Programme. Three weeks later she reaches the emergency department with vertical nystagmus and a broad-based gait; her serum phenytoin is 32 micrograms/mL. The isoniazid has inhibited phenytoin's already saturated metabolism. Management is phenytoin dose reduction with level-guided retitration — and planning ahead, because if her regimen later changes to one containing rifampicin from the start, induction would swing her the other way toward seizures. Her file should also carry the contraceptive note: phenytoin renders a combined OCP unreliable.

The same logic protects a different patient: a young man with newly diagnosed focal epilepsy who needs contraception advice for his partner-free future planning, or the woman started on lamotrigine while already taking valproate — her titration is halved from day one, because the alternative is a rash that hospitalises.

## Where students slip

The classic wrong answer is treating interactions as trivia rather than prescriptions. When NBE offers "advise barrier contraception additionally" versus "stop the antiepileptic" for a woman on carbamazepine wanting contraception, the first is correct; when it asks which antiepileptic level rises with valproate co-therapy, the answer is lamotrigine and the consequence is a rash, not merely a number. Candidates also forget direction: rifampicin lowers phenytoin, isoniazid raises it, and a single TB regimen can contain both forces. Finally, the lamotrigine-OCP rule has two directions — starting the pill drops levels toward seizures; stopping it after long co-therapy raises them toward toxicity — and examiners delight in the second, less-taught limb.

## Frequently asked questions

### Why do enzyme-inducing antiepileptics cause contraceptive failure?

Carbamazepine, phenytoin and phenobarbitone induce CYP3A4, accelerating oestrogen and progestogen metabolism, so a standard combined pill delivers subeffective steroid exposure.

### How does valproate change lamotrigine dosing?

Valproate inhibits lamotrigine glucuronidation, roughly doubling its levels, so the lamotrigine dose is halved and titration slowed to avoid serious rash.

### Which anti-tubercular drug causes phenytoin toxicity?

Isoniazid, by inhibiting phenytoin metabolism in a zero-order kinetic system — nystagmus and ataxia appear with only small dose excesses.

### What happens if meropenem is given with valproate?

Carbapenems markedly lower serum valproate, risking breakthrough seizures within days — the valproate should be replaced with another agent rather than merely increased.

### Which antiepileptics have the fewest drug interactions?

Levetiracetam, gabapentin and pregabalin, which are renally cleared with minimal hepatic enzyme involvement — preferred in polypharmacy, elderly patients and transplant recipients.